Ocumetics Technology (TSXV:OTC) EBIT : C$-3.57 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ocumetics Technology EBIT?

Ocumetics Technology's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was C$-0.62 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-3.57 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ocumetics Technology's annualized ROC % for the quarter that ended in Mar. 2024 was -343.18%. Ocumetics Technology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -3,775.76%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ocumetics Technology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -9.87%.

Ocumetics Technology EBIT Historical Data

The historical data trend for Ocumetics Technology's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumetics Technology EBIT Chart

Ocumetics Technology Annual Data

Trend

Jul20

Jul21

Dec22

Dec23

EBIT

-0.17

-0.65

-2.19

-3.61

Ocumetics Technology Quarterly Data
	Jul20	Jul21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial							-0.67	-1.49	-0.74	-0.71	-0.62

Competitive Comparison of Ocumetics Technology's EBIT

For the Medical Instruments & Supplies subindustry, Ocumetics Technology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocumetics Technology's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ocumetics Technology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ocumetics Technology's EV-to-EBIT falls into.

Ocumetics Technology EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-3.57 Mil.

Ocumetics Technology (TSXV:OTC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ocumetics Technology's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-2.464 * ( 1 - 0% )	/	( (0.725	+	0.711)	/ 2 )
=	-2.464	/	0.718
=	-343.18 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1.036	-	0.624	-	( 0.236	-	max(0, 0.624	-	0.311	+	0.236	))
=	0.725

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.947	-	0.853	-	( 0.117	-	max(0, 0.853	-	0.236	+	0.117	))
=	0.711

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Ocumetics Technology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-2.492	/	( ( (0.068 + max(-0.593, 0))	+	(0.064 + max(-0.79, 0)) )	/	2 )
=	-2.492	/	( ( 0.068	+	0.064 )	/	2 )
=	-2.492	/	0.066
=	-3,775.76 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.031)	-	(0.624	+	0	+	0)
=	-0.593

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.063)	-	(0.853	+	0	+	0)
=	-0.79

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ocumetics Technology's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-3.569	/	36.143
	=	-9.87 %

Ocumetics Technology EBIT Related Terms

Thank you for viewing the detailed overview of Ocumetics Technology's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumetics Technology (TSXV:OTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ocumetics Technology Corp (TSXV:OTC) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

OTCFF:USA

Address

639 - 5th Avenue S.W., Suite 1250, Calgary, AB, CAN, T2P 0M9

Website

https://www.ocumetics.com

Ocumetics Technology Corp is a Canadian-based research and product development company. The company is engaged in developing an accommodating intraocular lens to eliminate the need for corrective lenses, especially for people over 45 years of age.

Executives

Roger Jewett

Director, Senior Officer

Ocumetics Technology (TSXV:OTC) Headlines

No Headlines